DE2329412C3 - Suspension mit einem Gehalt an beschichteten Methenaminmandelatteilchen - Google Patents
Suspension mit einem Gehalt an beschichteten MethenaminmandelatteilchenInfo
- Publication number
- DE2329412C3 DE2329412C3 DE2329412A DE2329412A DE2329412C3 DE 2329412 C3 DE2329412 C3 DE 2329412C3 DE 2329412 A DE2329412 A DE 2329412A DE 2329412 A DE2329412 A DE 2329412A DE 2329412 C3 DE2329412 C3 DE 2329412C3
- Authority
- DE
- Germany
- Prior art keywords
- methenamine
- suspension
- particles
- almondate
- coated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- VKYKSIONXSXAKP-UHFFFAOYSA-N hexamethylenetetramine Chemical compound C1N(C2)CN3CN1CN2C3 VKYKSIONXSXAKP-UHFFFAOYSA-N 0.000 title claims description 76
- 235000010299 hexamethylene tetramine Nutrition 0.000 title claims description 74
- 229960004011 methenamine Drugs 0.000 title claims description 74
- 239000000725 suspension Substances 0.000 title claims description 54
- 239000002245 particle Substances 0.000 title claims description 36
- 239000003381 stabilizer Substances 0.000 claims description 13
- 235000019640 taste Nutrition 0.000 description 25
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 24
- 235000019325 ethyl cellulose Nutrition 0.000 description 24
- 239000001856 Ethyl cellulose Substances 0.000 description 23
- 229920001249 ethyl cellulose Polymers 0.000 description 23
- 239000011248 coating agent Substances 0.000 description 22
- 238000000576 coating method Methods 0.000 description 20
- 239000002202 Polyethylene glycol Substances 0.000 description 18
- 229920001223 polyethylene glycol Polymers 0.000 description 18
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 15
- ULQISTXYYBZJSJ-UHFFFAOYSA-N 12-hydroxyoctadecanoic acid Chemical compound CCCCCCC(O)CCCCCCCCCCC(O)=O ULQISTXYYBZJSJ-UHFFFAOYSA-N 0.000 description 14
- 239000000203 mixture Substances 0.000 description 14
- 238000002360 preparation method Methods 0.000 description 14
- 239000003240 coconut oil Substances 0.000 description 13
- 235000019864 coconut oil Nutrition 0.000 description 13
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 12
- 239000002904 solvent Substances 0.000 description 10
- 229920000642 polymer Polymers 0.000 description 9
- 230000009967 tasteless effect Effects 0.000 description 9
- 244000144725 Amygdalus communis Species 0.000 description 8
- 235000011437 Amygdalus communis Nutrition 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 235000020224 almond Nutrition 0.000 description 8
- 238000002844 melting Methods 0.000 description 8
- 230000008018 melting Effects 0.000 description 8
- 238000001694 spray drying Methods 0.000 description 8
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 8
- 235000015112 vegetable and seed oil Nutrition 0.000 description 8
- 239000008158 vegetable oil Substances 0.000 description 8
- 229940114072 12-hydroxystearic acid Drugs 0.000 description 7
- 239000004480 active ingredient Substances 0.000 description 7
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 7
- 239000004359 castor oil Substances 0.000 description 6
- 235000019438 castor oil Nutrition 0.000 description 6
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 6
- 231100000252 nontoxic Toxicity 0.000 description 6
- 230000003000 nontoxic effect Effects 0.000 description 6
- 239000003765 sweetening agent Substances 0.000 description 6
- 239000008122 artificial sweetener Substances 0.000 description 5
- 235000021311 artificial sweeteners Nutrition 0.000 description 5
- 235000003599 food sweetener Nutrition 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 239000003814 drug Substances 0.000 description 4
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 210000001035 gastrointestinal tract Anatomy 0.000 description 3
- UXNFIJPHRQEWRQ-UHFFFAOYSA-N hexamethylenetetramine mandelate salt Chemical compound C1N(C2)CN3CN1CN2C3.OC(=O)C(O)C1=CC=CC=C1 UXNFIJPHRQEWRQ-UHFFFAOYSA-N 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 229940126601 medicinal product Drugs 0.000 description 3
- 229960002786 methenamine mandelate Drugs 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 3
- 229960003415 propylparaben Drugs 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000011877 solvent mixture Substances 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000007888 film coating Substances 0.000 description 2
- 238000009501 film coating Methods 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 235000013355 food flavoring agent Nutrition 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 235000019204 saccharin Nutrition 0.000 description 2
- 229940081974 saccharin Drugs 0.000 description 2
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 2
- 239000008159 sesame oil Substances 0.000 description 2
- 235000011803 sesame oil Nutrition 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Natural products CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 101100444142 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) dut-1 gene Proteins 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 235000019647 acidic taste Nutrition 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 238000000889 atomisation Methods 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- IXGDPRSVHMKXER-UHFFFAOYSA-N butyl acetate;dichloromethane Chemical compound ClCCl.CCCCOC(C)=O IXGDPRSVHMKXER-UHFFFAOYSA-N 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000008199 coating composition Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000004312 hexamethylene tetramine Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 239000008297 liquid dosage form Substances 0.000 description 1
- 239000012263 liquid product Substances 0.000 description 1
- 239000006194 liquid suspension Substances 0.000 description 1
- IWYDHOAUDWTVEP-UHFFFAOYSA-M mandelate Chemical compound [O-]C(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-M 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000012053 oil suspension Substances 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 229940100692 oral suspension Drugs 0.000 description 1
- 125000006353 oxyethylene group Chemical group 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 239000008200 pharmaceutical coating composition Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 239000011253 protective coating Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 235000021092 sugar substitutes Nutrition 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5015—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Seeds, Soups, And Other Foods (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26837172A | 1972-07-03 | 1972-07-03 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DE2329412A1 DE2329412A1 (de) | 1974-01-31 |
| DE2329412B2 DE2329412B2 (de) | 1978-07-13 |
| DE2329412C3 true DE2329412C3 (de) | 1979-04-19 |
Family
ID=23022703
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE2329412A Expired DE2329412C3 (de) | 1972-07-03 | 1973-06-08 | Suspension mit einem Gehalt an beschichteten Methenaminmandelatteilchen |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US3780170A (enExample) |
| JP (1) | JPS4955816A (enExample) |
| AU (1) | AU469349B2 (enExample) |
| CA (1) | CA1007988A (enExample) |
| DE (1) | DE2329412C3 (enExample) |
| DK (1) | DK133083C (enExample) |
| FR (1) | FR2190466B1 (enExample) |
| GB (1) | GB1379534A (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3879511A (en) * | 1972-07-03 | 1975-04-22 | Warner Lambert Co | Tasteless methenamine mandelate in a stabilized vegetable oil suspension |
| JPS56140915A (en) * | 1980-04-07 | 1981-11-04 | Yamanouchi Pharmaceut Co Ltd | Pharmaceutical preparation for solid drug |
| US4349529A (en) * | 1980-04-14 | 1982-09-14 | E. R. Squibb & Sons, Inc. | Diagnostic and therapeutic capsules and method of producing |
| US4828857A (en) * | 1984-10-05 | 1989-05-09 | Warner-Lambert Company | Novel sweetener delivery systems |
| US4797288A (en) * | 1984-10-05 | 1989-01-10 | Warner-Lambert Company | Novel drug delivery system |
| US4804548A (en) * | 1984-10-05 | 1989-02-14 | Warner-Lambert Company | Novel sweetener delivery systems |
| US4764375A (en) * | 1985-09-11 | 1988-08-16 | Kv Pharmaceutical Company | Sachet drug delivery system |
| SE8605515D0 (sv) * | 1986-12-22 | 1986-12-22 | Astra Laekemedel Ab | A liquid dosage form for oral administration of a pharmaceutically active substance |
| DE69129036T2 (de) * | 1990-11-30 | 1998-07-30 | Yamanouchi Pharma Co Ltd | Überdeckte zusammensetzung mit schneller freisetzung |
| TW241194B (enExample) * | 1991-12-27 | 1995-02-21 | Takeda Pharm Industry Co Ltd | |
| US6818597B2 (en) * | 2000-04-21 | 2004-11-16 | Benchmark Research & Technology, Inc. | Suspensions of water soluble polymers in surfactant free non-aqueous solvents |
| US6743756B2 (en) * | 2001-01-26 | 2004-06-01 | Benchmark Research And Technology, Inc. | Suspensions of particles in non-aqueous solvents |
| IL268457B (en) | 2019-08-04 | 2022-05-01 | Omega 3 Galilee Ltd | Oil- suspension of edible solids and methods of preparing the same |
-
1972
- 1972-07-03 US US00268371A patent/US3780170A/en not_active Expired - Lifetime
-
1973
- 1973-06-08 DE DE2329412A patent/DE2329412C3/de not_active Expired
- 1973-06-19 AU AU57079/73A patent/AU469349B2/en not_active Expired
- 1973-06-25 GB GB3006273A patent/GB1379534A/en not_active Expired
- 1973-06-29 CA CA175,247A patent/CA1007988A/en not_active Expired
- 1973-06-29 DK DK362973*A patent/DK133083C/da active
- 1973-07-02 JP JP48074678A patent/JPS4955816A/ja active Pending
- 1973-07-03 FR FR7324454A patent/FR2190466B1/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| FR2190466A1 (enExample) | 1974-02-01 |
| JPS4955816A (enExample) | 1974-05-30 |
| DE2329412A1 (de) | 1974-01-31 |
| FR2190466B1 (enExample) | 1977-07-15 |
| DK133083B (da) | 1976-03-22 |
| US3780170A (en) | 1973-12-18 |
| DE2329412B2 (de) | 1978-07-13 |
| GB1379534A (en) | 1975-01-02 |
| AU469349B2 (en) | 1976-02-12 |
| AU5707973A (en) | 1974-12-19 |
| DK133083C (da) | 1976-08-23 |
| CA1007988A (en) | 1977-04-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69104079T2 (de) | Sirup. | |
| DE2418345C2 (de) | Pharmazeutisches Mittel für äußerliche Anwendung an menschlicher Haut | |
| AT396329B (de) | Pharmazeutische granulate und verfahren zu ihrer herstellung | |
| DE3124014A1 (de) | Aluminiumibuprofensuspensionen | |
| DE1106454B (de) | UEberzugsmittel fuer Arzneistoffe | |
| DE3013839A1 (de) | Verfahren zur herstellung einer aktivierten pharmazeutischen zusammensetzung | |
| DE3853341T2 (de) | Form zur verzögerten Diltiazemfreisetzung sowie das daraus hergestellte Arzneimittel. | |
| DE60026295T2 (de) | Pflanzenmaterial enthaltendes granulat und verfahren zur herstellung | |
| DE2329412B2 (de) | Suspension mit einem Gehalt an beschichteten Methenammandelatteilchen | |
| DE69424033T2 (de) | Pharmazeutische träger zur topischen ophthalmischen anwendung | |
| DE60100389T2 (de) | Fettlösliche Substanzen enthaltende Granulate und Verfahren zu ihrer Herstellung | |
| US3879511A (en) | Tasteless methenamine mandelate in a stabilized vegetable oil suspension | |
| EP2632443B1 (de) | Herstellung orodispersibler filme | |
| DE2149699A1 (de) | Pharmazeutische Zusammensetzungen mit verzoegerter Wirkstoff-Freisetzung | |
| DE60017881T2 (de) | Trinkbare pharmazeutische suspension von ibuprofen | |
| DE69003960T2 (de) | Die Verwendung von deacetyliertem Chitin zur Herstellung eines Medikamentes für die Behandlung von entzündliche Krankheiten. | |
| DE2434849C2 (de) | Herzstärkende Dosierungseinheit mit Gelatinekapsel | |
| DE1617522A1 (de) | Verfahren zur Herstellung einer Arzneimittelzubereitung | |
| EP1572344B1 (de) | Pellets und verfahren zu seiner herstellung | |
| DE3509741A1 (de) | Orale dosierungsform von etoposid | |
| DE1617309C3 (de) | Verfahren zur Herstellung von pharmazeutischen Präparaten mit Vitamingehalt | |
| DE3003147A1 (de) | Suppositorium mit einem gehalt an sulfamethoxazol und trimethoprim | |
| DE1467788C (de) | Wässrige oder wässrig alkoholische peroral einzunehmende Arzneimittellosung | |
| DE1467919C (de) | Verwendung des Aluminiumsalzes der O-Acetylsalicylsäure in festen Arzneizubereitungsformen mit Depot-Wirkung | |
| DE1901915C3 (de) | Arzneimittel auf der Basis von a -Aminobenzylpenicillintrihydrat |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C3 | Grant after two publication steps (3rd publication) | ||
| 8328 | Change in the person/name/address of the agent |
Free format text: HENKEL, G., DR.PHIL. FEILER, L., DR.RER.NAT. HAENZEL, W., DIPL.-ING., PAT.-ANW., 8000 MUENCHEN |
|
| 8339 | Ceased/non-payment of the annual fee |